Joseph R Hibbeln1, John M Davis. 1. LMBB, National Institutes Alcohol Abuse and Alcoholism, NIH, 5625 Fishers Lane, Rm 3N-07, MSC 9410, Bethesda, MD 20892, USA. jhibbeln@mail.nih.gov
Abstract
BACKGROUND: Adverse neurodevelopmental and neuropsychiatric outcomes have been established as signs of nutrient deficiencies and may be applicable to insufficient dietary intakes of omega-3 highly unsaturated fatty acids (n-3 HUFAs). OBJECTIVE: Consider if statistical definitions for Daily Reference Intakes can be applied to n-3 HUFAs intakes during pregnancy for maternal and neurodevelopmental deficiencies. DESIGN: Data were prospectively collected from women during pregnancy and children up to age 8 years participating in the Avon Longitudinal Study of Parents and Children (ALSPAC). Statistical analyses took social and lifestyle factors into account. RESULTS: During pregnancy, n-3 HUFA intakes from seafood that putatively meet statistical definitions of an estimated average requirement ranged from 0.05 to 0.06 en% (111-139 mg/d/2000 Cal) for suboptimal fine motor control at 42 m and 0.065-0.08 en% (114-181 mg/d/2000 Cal) for suboptimal verbal IQ at age 8 years and 0.18-0.22 en% (389-486 mg/d/2000 Cal) for maternal depression at 32 weeks. Intakes of n-3 ranging from 0.2 to 0.41 en% (445-917 mg/d/2000 Cal) prevented both increased risk of maternal depression and adverse neurodevelopmental outcomes for children among 97.5% of the population. No upper limit for safety was found. CONCLUSION: During pregnancy, a n-3 HUFA intake of 0.40 en% (900 mg/d/2000 Cal) from seafood is likely to meet the nutritional requirements for 97.5% of the mothers and children of this population. These considerations do not constitute DRI's for docosahexaenoic acid and n-3 HUFAs, but may contribute to their formulation.
BACKGROUND: Adverse neurodevelopmental and neuropsychiatric outcomes have been established as signs of nutrient deficiencies and may be applicable to insufficient dietary intakes of omega-3 highly unsaturated fatty acids (n-3 HUFAs). OBJECTIVE: Consider if statistical definitions for Daily Reference Intakes can be applied to n-3 HUFAs intakes during pregnancy for maternal and neurodevelopmental deficiencies. DESIGN: Data were prospectively collected from women during pregnancy and children up to age 8 years participating in the Avon Longitudinal Study of Parents and Children (ALSPAC). Statistical analyses took social and lifestyle factors into account. RESULTS: During pregnancy, n-3 HUFA intakes from seafood that putatively meet statistical definitions of an estimated average requirement ranged from 0.05 to 0.06 en% (111-139 mg/d/2000 Cal) for suboptimal fine motor control at 42 m and 0.065-0.08 en% (114-181 mg/d/2000 Cal) for suboptimal verbal IQ at age 8 years and 0.18-0.22 en% (389-486 mg/d/2000 Cal) for maternal depression at 32 weeks. Intakes of n-3 ranging from 0.2 to 0.41 en% (445-917 mg/d/2000 Cal) prevented both increased risk of maternal depression and adverse neurodevelopmental outcomes for children among 97.5% of the population. No upper limit for safety was found. CONCLUSION: During pregnancy, a n-3 HUFA intake of 0.40 en% (900 mg/d/2000 Cal) from seafood is likely to meet the nutritional requirements for 97.5% of the mothers and children of this population. These considerations do not constitute DRI's for docosahexaenoic acid and n-3 HUFAs, but may contribute to their formulation.
Authors: Anu W Turunen; Pia K Verkasalo; Hannu Kiviranta; Eero Pukkala; Antti Jula; Satu Männistö; Riina Räsänen; Jukka Marniemi; Terttu Vartiainen Journal: Int J Epidemiol Date: 2008-06-25 Impact factor: 7.196
Authors: K M Appleton; J V Woodside; J W G Yarnell; D Arveiler; B Haas; P Amouyel; M Montaye; J Ferrières; J B Ruidavets; P Ducimetiere; A Bingham; A Evans Journal: J Affect Disord Date: 2007-05-01 Impact factor: 4.839
Authors: Reeta Hakkarainen; Timo Partonen; Jari Haukka; Jarmo Virtamo; Demetrius Albanes; Jouko Lönnqvist Journal: Am J Psychiatry Date: 2004-03 Impact factor: 18.112
Authors: Tanya L Blasbalg; Joseph R Hibbeln; Christopher E Ramsden; Sharon F Majchrzak; Robert R Rawlings Journal: Am J Clin Nutr Date: 2011-03-02 Impact factor: 7.045
Authors: Michael D Lewis; Joseph R Hibbeln; Jeremiah E Johnson; Yu Hong Lin; Duk Y Hyun; James D Loewke Journal: J Clin Psychiatry Date: 2011-08-23 Impact factor: 4.384
Authors: Alexandra J Richardson; Jennifer R Burton; Richard P Sewell; Thees F Spreckelsen; Paul Montgomery Journal: PLoS One Date: 2012-09-06 Impact factor: 3.240
Authors: Christopher E Ramsden; Keturah R Faurot; Daisy Zamora; Olafur S Palsson; Beth A MacIntosh; Susan Gaylord; Ameer Y Taha; Stanley I Rapoport; Joseph R Hibbeln; John M Davis; J Douglas Mann Journal: Pain Date: 2015-04 Impact factor: 7.926
Authors: Christopher Ramsden; Christine Gagnon; Joseph Graciosa; Keturah Faurot; Robert David; J Alexander Bralley; R Norman Harden Journal: Pain Med Date: 2010-06-08 Impact factor: 3.637
Authors: Juliana dos Santos Vaz; Gilberto Kac; Pauline Emmett; John M Davis; Jean Golding; Joseph R Hibbeln Journal: PLoS One Date: 2013-07-12 Impact factor: 3.240